Attitude and Success Rate of Women with Pelvic Organ Prolapse on Self-management of Vaginal Pessary
Launched by CHINESE UNIVERSITY OF HONG KONG · Feb 6, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how women with pelvic organ prolapse feel about managing their own treatment using a vaginal pessary, which is a device inserted into the vagina to support pelvic organs that may be falling out of place. The study aims to understand how comfortable women are with this self-management approach and what factors influence their acceptance of it. The trial is open to women aged 18 and older who need a vaginal pessary for their condition, but those with certain limitations, such as severe physical dependence or cognitive issues, cannot participate.
If you decide to join this study, you’ll be asked to share your thoughts and experiences regarding the use of a vaginal pessary. The information collected will help researchers better understand how to support women in managing their pelvic organ prolapse effectively. This is an important step in improving treatment options and ensuring that women feel empowered in their healthcare decisions.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patient who suffers from pelvic organ prolapse requiring use of vaginal ring pessary as treatment
- Exclusion Criteria:
- • 1. Physically dependent in their daily living
- • 2. Limited physical dexterity due to medical conditions, for example: Parkinsonism or stroke
- • 3. Pregnancy
- • 4. Cognitive deficit preventing informed consenting procedure and self management
- • 5. Age lower than 18
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Shing Chee Symphorosa CHAN
Principal Investigator
O&G, PWH
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported